This information suggests that the presence of GLP-1R could indicate early-stage prostate cancer, and using a GLP-1RA could be a treatment for patients with type 2 diabetes mellitus and early-stage prostate cancer complications [16]. This evidence concerns the gene GLP1R and prostate cancer.